Bill Title: To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.

Sponsorship: Partisan Bill (Democrat 1)

Status: (Introduced - Dead) 2023-11-17 - Referred to the Subcommittee on Health. [HB6400 Detail]

Text: Latest bill text (Introduced) [PDF]

---

PolitiCorps Conversations

Start PolitiCorps Debate

Title	PolitiCorps	Access	Comments	Views	Last Post
There are no visible public or private PolitiCorps discussions concerning the 2023 US Congress HB6400 at this time.